Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-10-03
2006-10-03
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S249000, C514S303000, C514S365000, C514S465000, C540S597000, C544S060000, C544S124000, C544S350000, C546S118000, C546S122000, C546S269700, C546S290000, C548S181000, C548S400000, C549S435000
Reexamination Certificate
active
07115596
ABSTRACT:
The present invention relates to a class of compounds represented by the Formula Ior a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the αvβ3and/or the αvβ5integrin without significantly inhibiting the αvβ6integrin.
REFERENCES:
patent: 5700823 (1997-12-01), Hirth et al.
patent: 5773646 (1998-06-01), Chandrakumar et al.
patent: 5849736 (1998-12-01), Wityak et al.
patent: 5852210 (1998-12-01), Chen et al.
patent: 2003/0073688 (2003-04-01), Vianello et al.
patent: 2327672 (1999-02-01), None
patent: WO 92/07468 (1992-05-01), None
patent: WO 94/08577 (1994-04-01), None
patent: WO 97/44333 (1997-11-01), None
patent: WO 98/18461 (1998-05-01), None
patent: WO 99/26945 (1999-06-01), None
patent: WO 99/30709 (1999-06-01), None
patent: WO 99/30713 (1999-06-01), None
patent: WO 00/07544 (2000-02-01), None
patent: WO 00/33838 (2000-06-01), None
patent: WO 00/72801 (2000-12-01), None
patent: WO 01/24797 (2001-04-01), None
patent: WO 01/96334 (2001-12-01), None
patent: WO 02/081497 (2002-10-01), None
patent: WO 2002088118 (2002-11-01), None
Tavecchia et al. “Revised Structure of the Antibiotic GE 2270A” The Journal of Antibiotics, 1994, 1564-1567.
Bal et al., “Oxidation of α,β-Unsaturated Aldehydes”, Tetrahedron, 1981, 37: 2091-2096.
Bedford et al., “Nonquaternary Cholinesterase Reactivators. 3. 3(5)-Substituted 1,2,4-Oxadiazol-5(3)-aldoximes and 1,2,4-Oxidiazole-5(3)-thiocarbohydroximates as Reactivators of Organophosphonate-Inhibited Eel and Human Acetylcholinesterase in Vitro”, Journal of Medicinal Chemistry, 1986, 29: 2174-2183.
Berge et al., “Pharmaceutical Salts”, Journal of Pharmaceutical Sciences, 1977, 66(1): 1-19.
Brown et al., “Lignanes. 18. Synthése Totale et Confirmation de la Structure de I'Acid Mégacérotonique”, Tetrahedron, 1995, 51: 13061-13072.
Charo et al., “Inhibition of Fibrinogen Binding to GP IIb/IIIa by a GP IIIa Peptide”, Journal of Biological Chemistry, 1991, 266(3): 1415-1421.
Cornforth et al., “A Synthesis of Acylamidomalondialdehydes” Journal of the Chemical Society, 1949, 1550.
Diederich et al., “A Water-Soluble Tetraoxa[7.1.7.1] paracyclophane: Synthesis and Host-Guest Interactions with Alicyclic and Cationic Aromatic Guest Molecules in Aqueour Solution”, Chemische Berichte, 1985, 118: 3817-3829.
Ellison et al., “Cyclopentenone Synthesis Via Aldol Condensation. Synthesis of a Key Prostaglandin Intermediate”, Tetrahedron Letters, 1975, 8: 499-502.
Hofman et al., “Studies Directed Towards the Total Synthesis of (+)-Himbacine”, Journal of Synthetic Organic Chemistry, 1998, 479-489.
Huang et al., “Expression of the Human Integrin β6 Subunit in Alveolar Type II Cells and Bronchiolar Epithelial Cells Reverses Lung Inflammation in β6 Knockout Mice”, American Journal of Respiratory Cell and Molecular Biology, 1998, 19(4): 636-42.
Kirk et al., “Syntheses and Adrenergic Agonist Properties of Ring-Fluorinated Isoproterenols”, Journal Medicinal Chemistry, 1982, 25: 680-684.
Legters et al., “A Convenient Synthesis of Aziridine-2-carboxylic Esters”, Journal of the Royal Netherlands Chemical Society, 1992, 111(1): 1-15.
Mcelvain et al., “Piperidine Derivatives. XXX. 1,4-Dialkyl-4-arylpiperidines”, Journal of the American Chemical Society, 1958, 80: 3915-3923.
Muri et al., “Synthesis of New Benzylic Ethers of Oximes Derived from 1-Phenyl-Pyrazole Compounds”, Synthetic Communications, 1998, 28(7): 1299-1321.
Niiya et al., “Increased Surface Expression of the Membrane Glycoprotein IIb/IIIa Complex Induced by Platelet Activation: Relationships to the Binding of Fibrinogen and Platelet Aggregation”, Blood, 1987, 70: 475-483.
Pytela et al., “Arginine-Glycine-Aspartic Acid Adhesion Receptors”, Methods in Enzymology, 1987, 144: 475-489.
Sundberg et al., “Improved Procedures for Preparation of 4-Hydroxy- and 2-Amino-4-Methoxy-2-Aminopyridines”, Organic Preparations and Procedures Int., 1997, 29(1); 117-122.
Tokoroyama et al., “Folding Strain Stereocontrol in Cyclohexane Ring Formation by Means of an Intramolecular Ester Enolate Alkylation Reaction” Canadian Journal of Chemistry, 1996, 74(12): 2487-2502.
Vogel, “Physical Properties and Chemical Constitution. Part II Esters of ββ-Substituted Glutaric Acids”, Journal of the Chemical Society, 1934, 1758-1765.
Yatohgo et al., “Novel Purification of Vitronectin from Human Plasma by Heparin Affinity chromatography”, Cell Structure and Function, 1988, 13: 281-292.
Zelle et al., “A Simple, High-Yielding Method for the Methylenation of Catechols”, Tetrahedron Letters, 1991, 32: 2461-2464.
Zucker, “Platelet Aggregation Measured by the Photometric Method”, Methods in Enzymology, 1989, 169: 117-133.
International Search Report for PCT/US03/40629, dated May 7, 2004.
Plouvier et al., “Antitumor Combilexin. A Thiazole-Containing Analogue of Netropsin Linked to an Acridine Chromophore”, Bioconjugate Chem, 1994, 5(5), 475-481.
International Search Report for PCT/US03/40898, dated May 7, 2004.
Boys Mark L.
Chen Barbara B.
Downs Victoria L.
Penning Thomas D.
Russell Mark
Kosack Joseph R.
Pharmacia Corporation
Pugmire Matthew J.
Zielinski Bryan C.
LandOfFree
Thiazole compounds as integrin receptor antagonists derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiazole compounds as integrin receptor antagonists derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazole compounds as integrin receptor antagonists derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3702964